Form 4 for CC Chemours Co
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-02 · accession 0001627223-21-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-02 | CC | Newman Mark | Pres, CEO, Dir | S - Sale+OE | $29.94 | -34.3K | 145.5K | -19% | -$1.03M |
| D | 2021-12-03 | 2021-12-02 | CC | Newman Mark | Pres, CEO, Dir | M - OptEx | $18.45 | +34.3K | 179.7K | +24% | +$631.9K |
| D | 2021-12-03 | 2021-12-02 | CC | Newman Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -34.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | S | D | 34,252 | $29.94 | 145,458.58 | D | — | — | (F3) Shares were sold in multiple transactions at prices ranging from $29.51 to $30.16. (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units. |
| 2 | Common | Common Stock | 2021-12-02 | M | A | 34,252 | $18.45 | 179,710.58 | D | — | — | (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-02 | M | D | 34,252 | $0.00 | 0 | D | $18.45 · — to 2022-02-03 | 34,252 Common Stock | (F4) Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. |